SCHEMBL21783632

SCHEMBL21783632

CC(C)c1cccc(N)c1N(C)N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.40
GABRA1 P14867 3/20 0.40
TSHR P16473 3/20 0.40
GABRG2 P18507 2/20 0.40
GABRB3 P28472 2/20 0.40
GABRB2 P47870 2/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 2/20 0.40
FAAH O00519 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
LMNA P02545 1/20 0.40
GABRB1 P18505 1/20 0.40
PTGS1 P23219 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2C P28335 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
HTR2B P41595 1/20 0.40
GABRA2 P47869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30154737 0.86 GABRA1 (0.41) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL26127801 0.86 GABRA1 (0.41) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL59823 0.73 GABRA1 (0.50) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL29407112 0.72 CYP3A4 (0.48) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL104522 0.72 CYP3A4 (0.48) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL25105501 0.71 CYP3A4 (0.37) CYP3A4TSHRHPGDPIK3CACD44
SCHEMBL104513 0.71 GABRA1 (0.50) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL30223644 0.71 GABRA1 (0.50) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL22607091 0.71 GABRA1 (0.38) GABRA1GABRB2HIF1APOLBALDH1A1
SCHEMBL141144 0.70 CYP3A4 (0.46) CYP3A4GABRA1TSHRGABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047208-A1 INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2020-03-05 WO disclosed